The emerging field of bioelectronic medicine aims to target disorders traditionally treated with drugs and instead uses advanced neuromodulation devices that may offer significant advantages. In a recent breakthrough first-in-human study, scientists used a small implantable bioelectronic device that significantly improved measures of disease activity in patients with rheumatoid arthritis. The clinical trial data will be published in the Proceedings of the National Academy of Sciences (PNAS).